Skip to main content
  •   Home
  • 2026 Update 
    • Search for Activity
    • 2026 update
    • Search for Structure
    • 2026 update
  •   Download
  •   Manual

Natural Product (NP) Details

General Information of the NP (ID: NP8427)
Name
Phloroglucinol
Synonyms
phloroglucinol; 108-73-6; Benzene-1,3,5-triol; 1,3,5-trihydroxybenzene; 1,3,5-benzenetriol; Phloroglucin; Phloroglucine; Spasfon-Lyoc; s-Trihydroxybenzene; 5-Hydroxyresorcinol; Benzene-s-triol; 3,5-Dihydroxyphenol; Phloroglucinol anhydrous; Benzene, trihydroxy; sym-Trihydroxybenzene; 5-Oxyresorcinol; Dilospan S; Floroglucinol; Floroglucin; 5-Oxyresorcinolphloroglucin; 1,3,5-THB; 1,3,5-Trihydroxycyclohexatriene; 1,3,5-Triol; MFCD00002286; Benzene, 1,3,5-trihydroxy-; UNII-DHD7FFG6YS; Phloroglucinol, anhydrous; 5-Benzenetriol; 1,2,5-trihydroxybenzene; NSC 1572; Phloroglucinol (JAN); DHD7FFG6YS; CHEMBL473159; CHEBI:16204; NSC-1572; Floroglucin [Czech]; Floroglucinol [Czech]; Phloroglucinol, 99+%, anhydrous; CCRIS 4147; NCGC00166270-01; EINECS 203-611-2; BRN 1341907; AI3-08848; phloroglucinol ts; 1,5-Benzenetriol; 13X; Dilospan S (TN); PubChem2603; Phloroglucinol [BAN]; 1,5-Trihydroxybenzene; 1,5-Triol; Benzene,3,5-trihydroxy-; WLN: QR CQ EQ; 1,3,5-trihydroxylbenzene; 1,3,5-trihydroxy benzene; 1,3,5-trihydroxy-benzene; 1,3, 5-Trihydroxybenzene; SCHEMBL26311; 1,5-Trihydroxycyclohexatriene; 4-06-00-07361 (Beilstein Handbook Reference); Phloroglucinol, p.a., 99%; DTXSID9048354; NSC1572; ZINC391883; ACT13446; ANW-15974; BBL018701; BDBM50249069; STL146346; phloroglucinol (1,3,5-benzenetriol); Phloroglucinol, >=99.0% (HPLC); AKOS000119851; AM84333; AS04650; DB12944; FS-4574; MCULE-5869131240; 1,3,5-Benzenetriol (ACD/Name 4.0); NCGC00166270-02; AC-10081; FT-0606511; FT-0673853; P0249; P1376; ST50214381; A-8565; C02183; D00152; A801919; Q899008; Q-200070; Phloroglucinol, plant cell culture tested, BioReagent; F0001-0177; Phloroglucinol, Used to detect the presence of wood fiber.; Phloroglucinol (anhydrous), European Pharmacopoeia (EP) Reference Standard
    Click to Show/Hide
Species Origin Dryopteris arguta ...     Click to Show/Hide
Dryopteris arguta
Kingdom: Viridiplantae
Phylum: Streptophyta
Class: Polypodiopsida
Order: Polypodiales
Family: Dryopteridaceae
Genus: Dryopteris
Species: Dryopteris arguta
Disease Urinary system disease [ICD-11: GC2Z] Approved [1]
Structure
Click to Download Mol
2D MOL

3D MOL

ADMET Property
Absporption
Caco-2 Permeability
 -5.065
 
MDCK Permeability
 -4.748
 
PAMPA
 -
 
HIA
 - - -
 
Distribution
VDss
 -0.043
 
PPB
 52.8%
 
BBB
 - -
 
Metabolism
CYP1A2 inhibitor
 +++
CYP1A2 substrate
 +++
CYP2C19 inhibitor
 ++
CYP2C19 substrate
 - - -
CYP2C9 inhibitor
 ++
CYP2C9 substrate
 ++
CYP2D6 inhibitor
 +++
CYP2D6 substrate
 +++
CYP3A4 inhibitor
 +++
CYP3A4 substrate
 - - -
CYP2B6 inhibitor
 +++
CYP2B6 substrate
 - - -
CYP2C8 inhibitor
 +++
HLM Stability
 +++
 
Excretion
CLplasma
 11.771
 
T1/2
 1.332
Toxicity
DILI
 - - -
 
Rat Oral Acute Toxicity
 -
 
FDAMDD
 ++
 
Respiratory
 +
 
Human Hepatotoxicity
 -
 
Ototoxicity
 - -
 
Drug-induced Nephrotoxicity
 - - -
 
Drug-induced Neurotoxicity
 -
 
Hematotoxicity
 - - -
 
Genotoxicity
 +++
 
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++). 2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
    Click to Show/Hide
    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C6H6O3
PubChem CID
359
Canonical SMILES
C1=C(C=C(C=C1O)O)O
InChI
1S/C6H6O3/c7-4-1-5(8)3-6(9)2-4/h1-3,7-9H
InChIKey
QCDYQQDYXPDABM-UHFFFAOYSA-N
CAS Number
CAS 108-73-6
ChEBI ID
CHEBI:16204
Herb ID
HBIN039582
TTD Drug ID
D07EXH
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Parecoxib      Gastrointestinal stromal tumor     Click to Show/Hide the Molecular Data of This Drug
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Experimental
                    Result(s)
Parecoxib in combination with phloroglucinol for acute renal colic has a faster action, also reduces the demand of rescue analgesics.
References
Reference 1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Reference 2 Efficacy and safety of parecoxib/phloroglucinol combination therapy versus parecoxib monotherapy for acute renal colic: a randomized, double-blind clinical trial. Cell Biochem Biophys. 2014 May;69(1):157-61.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (suilab@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China